or international healthcare organizations—will help tailor your submission to meet their needs.

Impact of PQ: Gaining WHO PQ can significantly influence your market access strategy, especially in low- and middle-income countries.

Next, manufacturers should acquire familiarity with the legal frameworks that govern PQ. This understanding will guide the subsequent steps of dossier preparation and submission.

Step 2: Dossier Preparation

The preparation of the PQ dossier requires the consolidation of various critical documents. The WHO Good Manufacturing Practices (GMP) guidelines are paramount, as adherence will be assessed during the inspection phase. Ensure you have the following elements in place:

• Quality Management System (QMS): Documentation that outlines your company’s policies regarding quality assurance and control. Compliance with WHO GMP is non-negotiable.
• Product Information: Include comprehensive product details, clinical data, stability data, and results of bioequivalence studies (if applicable).
• Labeling and Packaging: Proposed product labeling must be in accordance with WHO guidelines to facilitate the acceptance of the product in diverse markets.

Furthermore, assembling the dossier is not merely about document submission but ensuring each file meets WHO’s technical requirements. Critical documents include:

• WHO TRS guidelines adherence documentation
• true copies of manufacturing licenses and GMP certificates
• an up-to-date summary of quality control test results

Manufacturers should also prepare to provide comprehensive information about their manufacturing facilities. This includes site plans, equipment descriptions, manufacturing process flows, and quality assurance measures. Ensure that your site is ready for an inspection readiness assessment by internal stakeholders before submission.

Step 3: Submission Process

With a complete dossier in hand, the next step is the actual submission to WHO for prequalification. This involves both electronic and paper submissions. Ensure to comply with the following steps:

• Choose a suitable submission format: WHO accepts submissions in electronic format through the WHO PQ e-submission portal. However, hard copies may still be required in certain cases.
• Complete the application form: Ensure all fields are accurately filled out including product details, manufacturer information, and contact points.
• Prepare for fees: Consideration of submission fees is critical, ensure the correct financial arrangements are in place.

Following submission, keep track of correspondence with WHO. Timely responses to any queries will accelerate the review process.

Step 4: Review and Inspection

Once your dossier is submitted, the WHO will commence its review and inspection process. The timeline can vary, but readiness is critical for the manufacturer. Ensure that your operational and documentation processes are transparent and accessible for potential WHO inspectors. Understanding the review process is customizable but includes:

• Technical document assessment: Detailed review of the submitted documentation for compliance with WHO standards.
• Site inspection: An on-site evaluation of the manufacturing facility to verify compliance with GMP standards.
• Compliance follow-up: Address any findings or deficiencies noted during the inspection promptly to avoid delays in the final decision.

Be proactive in preparing your site for inspection—consider mock inspections to gauge compliance and resolve issues prior to the official assessment. Provide inspectors with access to all relevant areas and documentation to facilitate an efficient inspection process.

Step 5: Post-Approval Activities

Upon successful prequalification, your responsibilities do not end with approval. Engage in the following post-approval activities to maintain compliance and improve relationships with WHO and other stakeholders:

• Ongoing quality assurance: Regular review and quality control checks should continue to ensure no deviations occur.
• Reporting adverse events: Establish a system for post-market surveillance, adhering to both WHO guidelines and relevant FDA regulations.
• Renewal of PQ: Monitor expiration dates and initiate renewal processes as required to maintain ongoing PQ status.

In addition, recompiling and documenting all post-launch data can help improve future submissions and foster trust among your partners and clients. Engaging in continual learning about WHO updates is also vital for remaining compliant with the evolving regulatory landscape.

Conclusion

Successfully navigating the WHO Prequalification process as a US manufacturer demands a meticulous approach to documentation, compliance with WHO GMP standards, and readiness for inspections. Following the above steps will ensure that your products not only meet the necessary regulatory requirements but are likely to be successful in the competitive global market.

For further information and resources, consider reviewing WHO’s official publications and guidance documents that can bolster your understanding of the PQ process, including the detailed WHO Technical Report Series.